WuXi XDC Cayman Inc (2268.HK)
2268.HK Stock Price Chart
Explore WuXi XDC Cayman Inc interactive price chart. Choose custom timeframes to analyze 2268.HK price movements and trends.
2268.HK Company Profile
Discover essential business fundamentals and corporate details for WuXi XDC Cayman Inc (2268.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
18 Jun 2012
Employees
2.04K
Website
https://wuxixdc.comCEO
Jincai Li
Description
WuXi XDC Cayman Inc., an investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally. It engages in the discovery, research, development, and manufacture of antibody drug conjugates, bioconjugates, monoclonal antibody intermediates, and payload-linkers associated with bioconjugates. The company was founded in 2013 and is headquartered in Wuxi, China. WuXi XDC Cayman Inc. operates as a subsidiary of WuXi Biologics (Cayman) Inc.
2268.HK Financial Timeline
Browse a chronological timeline of WuXi XDC Cayman Inc corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 23 Mar 2026
Earnings released on 20 Aug 2025
Earnings released on 18 Aug 2025
EPS came in at ¥0.63 falling short of the estimated ¥0.67 by -6.44%, while revenue for the quarter reached ¥2.96B , beating expectations by +3.98%.
Earnings released on 24 Mar 2025
EPS came in at ¥0.52 surpassing the estimated ¥0.48 by +8.98%, while revenue for the quarter reached ¥2.54B , beating expectations by +14.15%.
Earnings released on 20 Aug 2024
EPS came in at ¥0.19 falling short of the estimated ¥0.25 by -23.19%, while revenue for the quarter reached ¥832.60M , missing expectations by -45.96%.
Earnings released on 30 Jun 2024
EPS came in at ¥0.19 , while revenue for the quarter reached ¥832.60M .
Earnings released on 31 Dec 2023
EPS came in at ¥0.05 falling short of the estimated ¥0.11 by -57.35%, while revenue for the quarter reached ¥565.19M , missing expectations by -40.81%.
Earnings released on 30 Sept 2023
EPS came in at ¥0.05 , while revenue for the quarter reached ¥565.19M .
Earnings released on 30 Jun 2023
EPS came in at ¥0.09 , while revenue for the quarter reached ¥505.88M .
Earnings released on 31 Mar 2023
EPS came in at ¥0.07 , while revenue for the quarter reached ¥487.59M .
Earnings released on 31 Dec 2022
EPS came in at ¥0.03 , while revenue for the quarter reached ¥330.49M .
Earnings released on 30 Jun 2022
EPS came in at ¥0.06 , while revenue for the quarter reached ¥208.01M .
Earnings released on 31 Mar 2022
EPS came in at ¥0.03 , while revenue for the quarter reached ¥121.43M .
2268.HK Stock Performance
Access detailed 2268.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.